ARDX vs CLOV · rev $333.6M vs rev $1.37B
Ardelyx Inc (ARDX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARDX revenue for 2024-12-31 was $333.6M. Net income was -$39.1M. Revenue was up 168.1% from 2023-12-31 to 2024-12-31. ARDX currently screens at market cap $1.37B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARDX currently screens at market cap $1.37B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARDX and CLOV stock pages for the full models.
Not investment advice.